Literature DB >> 25920351

A case-control study of stomach cancer in relation to Camellia sinensis in China.

Yue Wang1, Hong Duan2, Helen Yang3.   

Abstract

OBJECTIVE: The purpose of our study was to investigate the association between green tea (Camellia sinensis) drinking habits and risk of stomach cancer in China.
METHOD: A 1:2 matched hospital-based case-control study including 160 cases and 320 controls was conducted. A self-designed questionnaire was used to collect information on possible risk factors of stomach cancer, and to assess the green tea drinking habit. Conditional logistic regression was used to calculate odds ratios (ORs) and corresponding 95% confidence intervals (CIs). RESULT: Our study proposed that green tea was associated with risk of stomach cancer. Regular drinking (OR = 0.72), larger amount of consumption (≥35 g/week) (OR = 0.53) were protective factors. Among regular tea drinkers, lower temperature and longer interval between tea being poured and drunk also reduced the risk. Moreover, a strong agreement was found between temperature at which tea was drunk and tea interval (Correlation coefficient p value = 0.73).
CONCLUSION: Habits of green tea drinking, including regular drinking, larger amount of consumption, lower temperature and longer interval were strongly associated with a lower risk of stomach cancer.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Camellia sinensis; Case-control study; China; Green tea

Mesh:

Substances:

Year:  2015        PMID: 25920351     DOI: 10.1016/j.suronc.2015.02.002

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  6 in total

1.  Tea consumption and gastric cancer: a pooled analysis from the Stomach cancer Pooling (StoP) Project consortium.

Authors:  Georgia Martimianaki; Gianfranco Alicandro; Claudio Pelucchi; Rossella Bonzi; Matteo Rota; Jinfu Hu; Kenneth C Johnson; Charles S Rabkin; Linda M Liao; Rashmi Sinha; Zuo-Feng Zhang; Michela Dalmartello; Nuno Lunet; Samantha Morais; Domenico Palli; Monica Ferraroni; Guo-Pei Yu; Shoichiro Tsugane; Akihisa Hidaka; Maria Paula Curado; Emmanuel Dias-Neto; David Zaridze; Dmitry Maximovitch; Jesus Vioque; Manoli Garcia de la Hera; Lizbeth López-Carrillo; Raúl Ulises Hernández-Ramírez; Gerson Shigueaki Hamada; Mary H Ward; Lina Mu; Reza Malekzadeh; Farhad Pourfarzi; Antonia Trichopoulou; Anna Karakatsani; Robert C Kurtz; Areti Lagiou; Pagona Lagiou; Stefania Boccia; Paolo Boffetta; M Constanza Camargo; Eva Negri; Carlo La Vecchia
Journal:  Br J Cancer       Date:  2022-05-24       Impact factor: 9.075

Review 2.  Chronic Inflammatory Diseases and Green Tea Polyphenols.

Authors:  Helieh S Oz
Journal:  Nutrients       Date:  2017-06-01       Impact factor: 5.717

Review 3.  Effective Medicinal Plant in Cancer Treatment, Part 2: Review Study.

Authors:  Wesam Kooti; Karo Servatyari; Masoud Behzadifar; Majid Asadi-Samani; Fatemeh Sadeghi; Bijan Nouri; Hadi Zare Marzouni
Journal:  J Evid Based Complementary Altern Med       Date:  2017-03-31

4.  Association between tea consumption and risk of cancer: a prospective cohort study of 0.5 million Chinese adults.

Authors:  Xinyi Li; Canqing Yu; Yu Guo; Zheng Bian; Zewei Shen; Ling Yang; Yiping Chen; Yongyue Wei; Hao Zhang; Zhe Qiu; Junshi Chen; Feng Chen; Zhengming Chen; Jun Lv; Liming Li
Journal:  Eur J Epidemiol       Date:  2019-05-31       Impact factor: 8.082

5.  Risk Factors of Gastric Cancer in High-Risk Region of China: A Population-Based Case-control Study

Authors:  Ping Chen; Yulan Lin; Kuicheng Zheng; Baoying Liu; Chuancheng Wu; Wei Yan; Yuanhua Cai
Journal:  Asian Pac J Cancer Prev       Date:  2019-03-26

6.  Green tea (Camellia sinensis) for the prevention of cancer.

Authors:  Tommaso Filippini; Marcella Malavolti; Francesca Borrelli; Angelo A Izzo; Susan J Fairweather-Tait; Markus Horneber; Marco Vinceti
Journal:  Cochrane Database Syst Rev       Date:  2020-03-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.